Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Virtual Booth

Contact Supplier

Jai Radhe Sales is your partner for all your sourcing needs.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 1221416-43-8, Sis5bfo4wl, Ykp10811, Ykp-10811, (s)-(3-(4-(((4-amino-5-chloro-2-methoxybenzoyl)amino)methyl)piperidin-1- yl)-1-(4-fluorophenyl)propyl) carbamate, Unii-sis5bfo4wl

Molecular Formula

C₂₄H₃₀ClFN₄O₄

Molecular Weight

493.0 g/mol

InChI Key

KGMMSPVVHZGPHL-NRFANRHFSA-N

FDA UNII

SIS5BFO4WL

Relenopride has been used in trials studying the treatment of Chronic Idiopathic Constipation.

1 2D Structure

Relenopride

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

[(1S)-3-[4-[[(4-amino-5-chloro-2-methoxybenzoyl)amino]methyl]piperidin-1-yl]-1-(4-fluorophenyl)propyl] carbamate

2.1.2 InChI

InChI=1S/C24H30ClFN4O4/c1-33-22-13-20(27)19(25)12-18(22)23(31)29-14-15-6-9-30(10-7-15)11-8-21(34-24(28)32)16-2-4-17(26)5-3-16/h2-5,12-13,15,21H,6-11,14,27H2,1H3,(H2,28,32)(H,29,31)/t21-/m0/s1

2.1.3 InChI Key

KGMMSPVVHZGPHL-NRFANRHFSA-N

2.1.4 Canonical SMILES

COC1=CC(=C(C=C1C(=O)NCC2CCN(CC2)CCC(C3=CC=C(C=C3)F)OC(=O)N)Cl)N

2.1.5 Isomeric SMILES

COC1=CC(=C(C=C1C(=O)NCC2CCN(CC2)CC[C@@H](C3=CC=C(C=C3)F)OC(=O)N)Cl)N

2.2 Other Identifiers

2.2.1 UNII

SIS5BFO4WL

2.3 Synonyms

2.3.1 MeSH Synonyms

1. Carbamic Acid 3-(4-((4-amino-5-chloro-2-methoxybenzoylamino)methyl)piperidin-1-yl)-1-(4-fluorophenyl)propyl Ester

2. Ykp10811

2.3.2 Depositor-Supplied Synonyms

1. 1221416-43-8

2. Sis5bfo4wl

3. Ykp10811

4. Ykp-10811

5. (s)-(3-(4-(((4-amino-5-chloro-2-methoxybenzoyl)amino)methyl)piperidin-1- Yl)-1-(4-fluorophenyl)propyl) Carbamate

6. Unii-sis5bfo4wl

7. Relenopride [usan:inn]

8. Ykp 10811

9. Relenopride [inn]

10. Relenopride (usan/inn)

11. Relenopride [usan]

12. Relenopride [who-dd]

13. Gtpl8427

14. Schembl2335988

15. Chembl3544975

16. Dtxsid50153530

17. Db12798

18. [(1s)-3-[4-[[(4-amino-5-chloro-2-methoxybenzoyl)amino]methyl]piperidin-1-yl]-1-(4-fluorophenyl)propyl] Carbamate

19. D11220

20. Q27088530

21. (1s)-3-(4-((4-amino-5-chloro-2-methoxybenzamido)methyl)piperidin-1-yl)-1-(4-fluorophenyl)propyl Carbamate

22. Benzamide, 4-amino-n-((1-((3s)-3-((aminocarbonyl)oxy)-3-(4-fluorophenyl)propyl)-4-piperidinyl)methyl)-5-chloro-2-methoxy-

2.4 Create Date

2010-05-10

3 Chemical and Physical Properties

Molecular Formula	C₂₄H₃₀ClFN₄O₄
Molecular Weight	493.0 g/mol
XLogP3	3.2
Hydrogen Bond Donor Count	3
Hydrogen Bond Acceptor Count	7
Rotatable Bond Count	10
Exact Mass	492.1939613 g/mol
Monoisotopic Mass	492.1939613 g/mol
Topological Polar Surface Area	120 Å²
Heavy Atom Count	34
Formal Charge	0
Complexity	659
Isotope Atom Count	0
Defined Atom Stereocenter Count	1
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

ABOUT THIS PAGE

Find Relenopride manufacturers, exporters & distributors on PharmaCompass

Relenopride

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

PATENTS & EXCLUSIVITIES

DIGITAL CONTENT

GLOBAL SALES INFORMATION

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

What are you looking for?